Kimishige Ishizaka | Academic Influence

Kimishige Ishizaka's AcademicInfluence.com Rankings

Kimishige Ishizaka

Biology

#564

World Rank

#994

Historical Rank

Immunology

#19

World Rank

#22

Historical Rank

biology Degrees

Download Badge

Biology

Kimishige Ishizaka's Degrees

PhD Immunology University of Tokyo

Why Is Kimishige Ishizaka Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Kimishige "Kimi" Ishizaka was a Japanese immunologist who, with his wife Teruko Ishizaka, discovered the antibody class Immunoglobulin E in 1966–1967. Their work was regarded as a major breakthrough in the understanding of allergy. He was awarded the 1973 Gairdner Foundation International Award and the 2000 Japan Prize for his work in immunology.

(See a Problem?)

Kimishige Ishizaka's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Identification of gamma-E-antibodies as a carrier of reaginic activity. (1967) (525)
Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. (1966) (516)
Activation of the alternate pathway of human complements by rabbit cells. (1974) (432)
Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. (1966) (412)
Activation of mast cells for mediator release through IgE receptors. (1984) (357)
IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. (1973) (335)
Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. (1988) (323)
Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. (1993) (269)
Distribution of gamma E-forming cells in lymphoid tissues of the human and monkey. (1970) (230)
Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes. (1970) (227)
Regulation of IgE synthesis. (1984) (226)
Identification of basophil granulocytes as a site of allergic histamine release. (1972) (216)
An Essential Role of Mast Cells in the Development of Airway Hyperresponsiveness in a Murine Asthma Model (2000) (212)
Stimulation of phospholipid methylation, Ca2+ influx, and histamine release by bridging of IgE receptors on rat mast cells. (1980) (208)
Cellular events in the IgE antibody response. (1976) (196)
Genetic control of basal serum immunoglobulin E level and its effect on specific reaginic sensitivity. (1974) (194)
Diagnostic tests in ragweed hay fever. A comparison of direct skin tests, IgE antibody measurements, and basophil histamine release. (1973) (189)
Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes. (1967) (185)
Antioxidant status and nonspecific immune responses in rainbow trout (Oncorhynchus mykiss) fed two levels of vitamin E along with three lipid sources (2004) (175)
Development of human mast cells in vitro. (1989) (167)
Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity. (1975) (165)
Proteolytic degradation of exocrine and serum immunoglobulins. (1970) (160)
Human reaginic antibodies and immunoglobulin E. (1968) (158)
Mechanisms of passive sensitization. 3. Number of IgE molecules and their receptor sites on human basophil granulocytes. (1973) (156)
IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release. (1976) (148)
Triggering of histamine release from rat mast cells by divalent antibodies against IgE-receptors. (1978) (147)
Immunologic and cellular changes accompanying the therapy of pollen allergy. (1971) (141)
The capacity of human immunoglobulin E to mediate the release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung. (1970) (140)
Physicochemical properties of reaginic antibody: I. Association of reaginic activity with an immunoglobulin other than γA- or γG-globulin (1966) (140)
Lymphocytes bearing Fc receptors for IgE. I. Presence of human and rat T lymphocytes with Fc epsilon receptors. (1979) (139)
Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. (1995) (139)
Mechanisms of passive sensitization. IV. Dissociation of IgE molecules from basophil receptors at acid pH. (1974) (138)
IgE in atopic dermatitis. (1971) (136)
FEDERATION of American Societies for Experimental Biology. (1952) (134)
Biologic function of the Fc fragments of E myeloma protein. (1970) (133)
Pharmacologic inhibition of the antigen-induced release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE. (1971) (128)
Immunoglobulin E deficiency in ataxia-telangiectasia. (1969) (127)
Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses. (1976) (120)
Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells. (1983) (117)
Release of histamine and slow reacting substance of anaphylaxis (SRS-A) by IgE-anti-IgE reactions on monkey mast cells. (1972) (117)
Immunoglobulin switch circular DNA in the mouse infected with Nippostrongylus brasiliensis: evidence for successive class switching from mu to epsilon via gamma 1. (1990) (116)
Regulation of antibody response in vitro. VI. Carrier-specific helper cells for IgG and IgE antibody response. (1973) (114)
Clinical aspects of IgE myeloma. (1969) (114)
The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens (1988) (111)
Allergen-Binding Activity of γE, γG and γA Antibodies in Sera from Atopic Patients (1967) (111)
Biologic activity of aggregated gamma-globulin. II. A study of various methods for aggregation and species differences. (1960) (110)
Biological Activities of Aggregated Gamma Globulin I. Skin Reactive and Complement-Fixing Properties of Heat Denatured Gamma Globulin.∗ (1959) (109)
Direct demonstration of increased intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cell. (1984) (109)
Histamine release from human leukocytes by anti-gamma E antibodies. (1969) (106)
SURFACE IgE ON HUMAN BASOPHILS DURING HISTAMINE RELEASE (1973) (103)
Development of rat mast cells in vitro. I. Differentiation of mast cells from thymus cells. (1976) (103)
Reversed type allergic skin reactions by anti-gamma-E-globulin antibodies in humans and monkeys. (1968) (103)
Immunoglobulin E, a new class of human immunoglobulin. (1968) (103)
IgE-binding factors and regulation of the IgE antibody response. (1988) (98)
Morphologic and immunologic characterization of human basophils developed in cultures of cord blood mononuclear cells. (1985) (96)
Physicochemical properties of reaginic antibody: III. Further studies on the reaginic antibody in γA-globulin preparations (1966) (94)
Antigen-induced increase in protein kinase C activity in plasma membrane of mast cells. (1985) (93)
Degranulation of human basophil leukocytes by anti-gamma E antibody. (1971) (93)
Immunogenic properties of modified antigen E. II. Ability of urea-denatured antigen and alpha-polypeptide chain to prime T cells specific for antigen E. (1975) (93)
C'-1 fixation by human isoagglutinins: fixation of C'-1 by gamma-G and gamma-M but not by gamma-A antibody. (1966) (92)
Biological function of gamma E antibodies and mechanisms of reaginic hypersensitivity. (1970) (91)
Tyrosine Phosphorylation is Required for Mast Cell Activation by FcεRI Cross-Linking. (1992) (90)
Immune mechanisms of reversed type reaginic hypersensitivity. (1969) (89)
Measurement of IgE antibody by an antigen-binding assay: correlation with PK activity and IgG and IgA antibodies to allergens. (1978) (89)
Presence of γE in nasal washings and sputum from asthmatic patients (1970) (88)
Regulation of antibody response in vitro. VII. Enhancing soluble factors for IgG and IgE antibody response. (1973) (88)
Suspension culture of human mast cells/basophils from umbilical cord blood mononuclear cells. (1983) (88)
Induction of calcium flux across the rat mast cell membrane by bridging IgE receptors. (1979) (87)
Biological Activity of Soluble Antigen-Antibody Complexes: VII. Role of an Antibody Fragment in the Induction of Biological Activities (1962) (87)
Mechanisms of passive sensitization. II. Presence of receptors for IgE on monkey mast cells. (1971) (86)
Regulatory role of IgE-binding factors from rat T lymphocytes. III. IgE-specific suppressive factor with IgE-binding activity. (1980) (83)
Regulatory role of IgE-binding factors from rat T lymphocytes. I. Mechanism of enhancement of IgE response by IgE-potentiating factor. (1980) (81)
Measurement of IgG-blocking antibodies: development and application of a radioimmunoassay. (1976) (80)
Physicochemical Properties of Reaginic Antibody: VI. Effect of Heat on γE-, γG- and γA-Antibodies in the Sera of Ragweed Sensitive Patients (1967) (79)
Immunochemical properties of human gamma-A isohemagglutinin. I. Comparisons with gamma-G and gamma-M-globulin antibodies. (1965) (79)
Molecular Mimicry Between Insulin and Retroviral Antigen p73: Development of Cross-Reactive Autoantibodies in Sera of NOD and C57BL/KsJ db/db Mice (1988) (77)
Serum IgE studies in atopic dermatitis. (1973) (76)
In vitro reversed anaphylaxis: characteristics of anti-IgE mediated histamine release. (1970) (76)
Lymphocytes Bearing Fc Receptors for IgE: II. Induction of Fcε-Receptor Bearing Rat Lymphocytes by IgE (1979) (76)
Antigenic structure of gamma-E-globulin and reaginic antibody. (1967) (72)
A new concept of triggering mechanisms of IgE-mediated histamine release. (1978) (72)
Regulation of antibody response in vitro. IV. Heavy chain antigenic determinants on hapten-specific memory cells. (1972) (70)
A comparative antigenic study of gamma E-globulin and myeloma-IgND. (1969) (69)
Biologic activity of soluble antigen-antibody complexes. V. Change of optical rotation by the formation of skin reactive complexes. (1959) (68)
Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor. (1975) (68)
A research standard for human serum immunoglobulin E. (1970) (67)
Mechanisms of reaginic hypersensitivity: a review (1971) (67)
cDNA clones encoding IgE-binding factors from a rat-mouse T-cell hybridoma. (1985) (67)
Basic mechanisms of IgE-mediated hypersensitivity. (1989) (66)
IgA and IgA diphtheria antitoxin responses from human tonsil lymphocytes. (1975) (63)
Reaginic antibody formation in the mouse. VI. Suppression of IgE and IgG antibody responses to ovalbumin following the administration of high dose urea-denatured antigen. (1975) (63)
Reaginic antibody formation in the mouse. XI. Participation of long-lived antibody-forming cells in persistent antibody formation. (1981) (63)
Bridging of IgE receptors activates phospholipid methylation and adenylate cyclase in mast cell plasma membranes. (1981) (62)
Blocking of Prausnitz-Küstner sensitization with reagin by normal human β2A globulin (1963) (61)
Reaginic antibody formation in the mouse. VII. Induction of suppressor T cells for IgE and IgG antibody responses. (1976) (60)
Induction of erythema-wheal reactions by soluble antigen-gammaE antibody complexes in humans. (1968) (59)
Regulatory role of IgE-binding factors from rat T lymphocytes. II. Glycoprotein nature and source of IgE-potentiating factor. (1980) (58)
Biology of Immunoglobulin E (1975) (58)
Lymphocytes bearing Fc receptors for IgE. IV. Formation of IgE-binding factor by rat T lymphocytes. (1980) (57)
Blocking of passive sensitization of human mast cells and basophil granulocytes with IgE antibodies by a recombinant human epsilon-chain fragment of 76 amino acids. (1989) (55)
Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF. (2000) (55)
Immunogenic properties of modified antigen E. I. Presence of specific determinants for T cells in denatured antigen and polypeptide chains. (1974) (55)
THE BIOLOGICAL ACTIVITY OF SOLUBLE ANTIGEN-ANTIBODY COMPLEXES (1959) (55)
Immunogenic properties of modified antigen E. III. Effect of repeated injections of modified antigen on immunocompetent cells specific for native antigen. (1975) (55)
Immunologic characterization of serum factors responsible for cold urticaria. (1971) (55)
IgE formation in the rat following infection with Nippostrongylus brasiliensis. I. Proliferation and differentiation of IgE-bearing cells. (1976) (54)
Reaginic antibody formation in the mouse. II. Enhancement and suppression of anti-hapten antibody formation by priming with carrier. (1973) (53)
Demonstration of Fcγ Receptors on Human Basophil Granulocytes (1979) (51)
Immunoglobulin E. A new class of human immunoglobulin. (1968) (50)
Regulation of antibody response in vitro. 8. Multiplicity of soluble factors released from carrier-specific cells. (1974) (50)
Histamine release from rat mast cells by antibodies against rat basophilic leukemia cell membrane. (1977) (49)
Biologic activities of aggregated immunoglobulin E. (1970) (49)
Biologic activity of soluble antigen-antibody complexes. III. (1959) (48)
Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor. (1993) (46)
Physicochemical properties of reaginic antibody II. Characteristic properties of reaginic antibody different from human γA-isohemagglutinin and γD-globulin (1966) (46)
Modulation of the biologic activities of IgE-binding factors. I. Identification of glycosylation-inhibiting factor as a fragment of lipomodulin. (1983) (46)
Human IgG and IgA diphtheria antitoxins in serum, nasal fluids and saliva. (1969) (46)
Isotype-specific regulation of the IgE response by IgE-binding factors. (1983) (46)
Fixation of C' and C'la by rabbit gamma-G- and gamma-M-antibodies with particulate and soluble antigens. (1968) (46)
Rodent IgE-binding factor genes are members of an endogenous, retrovirus-like gene family. (1986) (46)
Release of histamine and arachidonate from mouse mast cells induced by glycosylation-enhancing factor and bradykinin. (1985) (46)
IgE levels in sera of children with asthma. (1971) (45)
Immunologic and physicochemical properties of enhancing soluble factors for IgG and IgE antibody responses. (1975) (44)
Complement fixation by aggregated IgE through alternate pathway. (1972) (44)
Presence of an antigenic determinant common to rat IgE-potentiating factor, IgE-suppressive factor, and Fc epsilon receptors on T and B lymphocytes. (1984) (44)
Biological Activity of Soluble Antigen-Antibody Complexes I. Skin Reactive Properties.∗ (1958) (43)
Induction of Fc epsilon-receptor bearing cells in vitro in human peripheral lymphocytes. (1980) (43)
Immunoglobulin E (IgE). (1985) (43)
Regulatory role of IgE-binding factors from rat T lymphocytes. V. The carbohydrate moieties in IgE-potentiating factors and IgE-suppressive factors. (1982) (43)
Biologic significance of disulfide bonds in human IgE molecules. (1975) (43)
Biological Activity of Aggregated γ-Globulin IV. Mechanism of Complement Fixation (1961) (42)
Formation of IgE binding factors by human T lymphocytes. (1981) (42)
Regulation of antibody response in vitro. X. Biphasic effect of cyclic AMP on the secondary anti-hapten antibody response to anti-immunoglobulin and enhancing soluble factor. (1976) (41)
Biological properties of a recombinant human immunoglobulin epsilon-chain fragment. (1986) (41)
Biological activity of aggregated gamma-globulin. III. Production of Arthus-like reactions. (1961) (41)
Human reaginic antibodies. (1970) (40)
Lymphocytes bearing Fc receptors for IgE. V. Effect of tunicamycin on the formation of IgE-potentiating factor and IgE-suppressive factor by con A-activated lymphocytes. (1981) (40)
Development of mast cells in vitro. II. Biologic function of cultured mast cells. (1977) (40)
The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets. (1996) (40)
Twenty years with IgE: from the identification of IgE to regulatory factors for the IgE response. (1985) (39)
Allergen-binding activity of gamma-E, gamma-G and gamma-A antibodies in sera from atopic patients. In vitro measurements of reaginic antibody. (1967) (39)
Immunoglobulin V gene replacement is caused by the intramolecular DNA deletion mechanism. (1992) (38)
Studies on the Food Poisoning Associated with Putrefaction of Marine Products–\I. An Outbreak of Allergy-like Food Poisoning Caused by “Sashimi” of P arathunnus mebachi and the Isolation of Causative Bacteria (1956) (38)
Regulatory role of IgE-binding factors from rat T lymphocytes. V. formation of IgE-potentiating factor by T lymphocytes from rats treated with Bordetella pertussis vaccine. (1981) (38)
Antigenic determinants specific for aggregated gamma G-globulins. (1968) (38)
Immunologic properties of mast cells from rats infected with Nippostrongylus brasiliensis. (1975) (38)
Identification of IgE. (2016) (37)
Immunoglobulin E synthesis in parasite infection. (1976) (37)
Immunoglobulin E in the monkey. (1969) (36)
Lymphocytes Bearing Receptors for IgE III. Transition of FcγR(+) Cells to FcεR(+) Cells by IgE (1979) (36)
Formation of IgE-binding factors by human T-cell hybridomas. (1984) (36)
Direct Demonstration of Reagin Activity in Purified γ1A-Globulin (1964) (36)
Biochemical analysis of desensitization of mouse mast cells. (1985) (35)
Studies on the immunogenicity of antigen-antibody precipitates. II. The suppressive effect of anti-carrier and anti-hapten antibodies on the immunogenicity of dinitrophenylated human gamma G globulin. (1968) (35)
Regulation of Immunoglobulin E Biosynthesis (1989) (35)
Internal Antigenic Determinants in Protein Molecules.∗ (1960) (35)
Regulation of antibody response in vitro. V. Effect of carrier-specific Helper cells on generation of hapten-specific memory cells of different immunoglobulin classes. (1973) (34)
Presence of reagin and γ1A-globulin in saliva (1964) (33)
A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia (1971) (33)
Physicochemical Properties of Reaginic Antibody (1966) (33)
IgE-binding factors from mouse T lymphocytes. I. Formation of IgE-binding factors by stimulation with homologous IgE and interferon. (1983) (32)
Induction of passive cutaneous anaphylaxis in monkeys by human γE antibody (1967) (32)
Biologic properties of E myeloma proteins. (1971) (31)
Regulatory role of IgE-binding factors from rat T lymphocytes. IV. Formation of IgE-binding factors in rats treated with complete Freund's adjuvant. (1980) (31)
IgE-binding factors from mouse T lymphocytes. II. Strain differences in the nature of IgE-binding factor. (1984) (31)
Possible role of IgE-mediated reaction in immunity (1974) (31)
Physicochemical and antigenic studies on human gamma E in respiratory fluid. (1970) (31)
Lymphocytes bearing Fc receptor for IgE. VIII. Affinity of mouse IgE for Fc epsilon R on Mouse B lymphocytes. (1982) (31)
Regulation of the IgE antibody response. (1981) (31)
Potentiation of IgE response in vitro by T cells from rats infected with Nippostrongylus brasiliensis. (1979) (31)
Formation of IgE-binding factors by rat T lymphocytes. III. Mechanisms of selective formation of IgE-suppressive factors by treatment with complete Freund's adjuvant. (1981) (30)
Failure of the putative IgE pentapeptide to compete with IgE for receptors on basophils and masts cells. (1977) (30)
IgE-Binding Factors (1985) (30)
Identification of γE-Antibodies as a Carrier of Reaginic Activity (1967) (30)
Regulation of antibody response in vitro. 3. Role of hapten-specific memory cells and carrier-specific helper cells on the distribution of anti-hapten antibodies in IgG, IgM and IgE classes. (1972) (30)
Formation of IgE-binding factors by T cells of patients infected with human immunodeficiency virus type 1. (1988) (30)
Suppression of IgE synthesis in mouse plasma cells and B cells by rat IgE-suppressive factor. (1984) (30)
Physicochemical properties of reaginic antibody. VI. Effect of heat on gamma-E-, gamma-G- and gamma-A-antibodies in the sera of ragweed sensitive patients. (1967) (30)
Association of protein-tyrosine kinase with phospholipase C-gamma 1 in bone marrow-derived mouse mast cells. (1992) (30)
Formation of IgE-binding factors by rat T lymphocytes. II. Mechanisms of selective formation of IgE-potentiating factors by treatment with Bordetella pertussis vaccine. (1981) (29)
Reaginic antibody formation in the mouse. I. Antibody-mediated suppression of reaginic antibody formation. (1972) (29)
Reaginic antibody formation in the mouse. VII. Depression of the ongoing IgE antibody formation by suppressor T cells. (1976) (29)
Immunoglobulins in bronchial tissues from patients with asthma, with special reference to immunoglobulin E (1971) (29)
Formation of IgE-binding factors by rat T lymphocytes. VI. Cellular mechanisms for the formation of IgE-potentiating factor and IgE-suppressive factor by antigenic stimulation of antigen-primed spleen cells. (1982) (29)
IgE-mediated triggering signals for mediator release from human mast cells and basophils. (1984) (28)
Physicochemical properties of reaginic antibody. 1. Association of reaginic activity with an immunoglobulin other than gammaA- or gammaG-globulin. (1966) (28)
Mast cells and IgE: from history to today. (2013) (28)
Specific binding of mouse IgE with rat mast cells. (1974) (28)
The significance of immunoglobulin E in reaginic hypersensitivity. (1970) (28)
Modulation of the biologic activities of IgE-binding factors. III. Switching of a T cell hybrid clone from the formation of IgE-suppressive factor to the formation of IgE-potentiating factor. (1983) (27)
Immunoglobulin E, a new class of human immunoglobulin. (1968) (27)
Skin reactions to anti-γE antibody in atopic, nonatopic, and immunologically deficient children and adults (1969) (27)
Immunosuppressive activities of recombinant glycosylation-inhibiting factor mutants. (1999) (27)
IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor. (1984) (27)
Formation of rat IgE-binding factors by rat-mouse T cell hybridomas. (1982) (27)
Preferential differentiation of inflammatory cells by recombinant human interleukins. (1989) (27)
Characteristics of complement fixation by aggregated IgE. (1972) (27)
Formation of IgE-binding factors by rat T lymphocytes. V. Effect of adjuvant for the priming immunization on the nature of IgE binding factors formed by antigenic stimulation. (1982) (26)
Regulation of antibody response in vitro. Suppression of secondary response by anti-immunoglobulin heavy chains. (1971) (26)
Modulation of the biologic activities of IgE-binding factor. IV. Identification of glycosylation-enhancing factor as a kallikrein-like enzyme. (1983) (26)
Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response. (1986) (26)
Human diphtheria antitoxin in immunoglobulin classes IgG and IgA. (1967) (26)
Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor. (1994) (25)
Effect of nonhydrolyzable guanosine phosphate on IgE-mediated activation of phospholipase C and histamine release from rodent mast cells. (1989) (25)
Induction of Fc epsilon receptors on mouse macrophages and lymphocytes by homologous IgE. (1986) (24)
Physico-Chemical Properties of Human Reaginic Antibody (1966) (24)
Regulation of antibody response in vitro. II. Formation of rabbit reaginic antibody. (1972) (24)
Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors. (1984) (24)
Regulatory effects of human IgE-binding factors on the IgE response of rat lymphocytes. (1986) (24)
SERUM PROTEINS IN SPUTUM OF PATIENTS WITH ASTHMA. (1964) (24)
A unique rabbit immunoglobulin having homocytotropic antibody activity. (1970) (24)
A simplified procedure for the preparation of immunoglobulin-class-specific antisera. (1969) (23)
Tyrosine phosphorylation is required for mast cell activation by Fc epsilon RI cross-linking. (1992) (23)
Immunochemical studies of dextran coupled ragweed pollen allergen, antigen E. (1975) (23)
Lymphocytes Bearing Fc Receptors for IgE (1979) (23)
Potentiating and suppressive IgE-binding factors are expressed by a single cloned gene. (1987) (23)
Mast Cell Activation and Mediator Release (1984) (22)
IgD-binding factors from mouse T lymphocytes. (1986) (22)
Regulation of IgE response by IgE-binding factors. (1981) (22)
Formation of IgE-binding factors by rat T lymphocytes. I. Induction of IgE-binding factors by poly I:C and interferon. (1981) (22)
Studies on the immunogenicity of antigen-antibody precipitates. 1. The suppressive effect of anti-L and anti-H chain antibodies on the immunogenicity of human gammaG globulin. (1968) (22)
Lymphocytes bearing Fc receptors for IgE. VI. Suppressive effect of glucocorticoids on the expression of Fc epsilon receptors and glycosylation of IgE-binding factors. (1981) (21)
CELL SURFACE IgE ON HUMAN BASOPHIL GRANULOCYTES * (1975) (21)
Reaginic antibody formation in the mouse. 3. Collaboration between hapten-specific memory cells and carrier-specific helper cells for secondary anti-hapten antibody formation. (1973) (20)
Induction of Reaginic Hypersensitivity (1979) (20)
Relationship among IgE-binding factors with various molecular weights. (1985) (19)
Lymphocytes bearing Fc receptors for IgE. VII. Possible participation of phospholipase A2 in the glycosylation of IgE-binding factors. (1981) (19)
IgE formation in the rat after infection with Nippostrongylus brasiliensis. II. Proliferation of IgE-bearing cells in neonatally thymectomized animals. (1977) (19)
Conversion of inactive glycosylation inhibiting factor to bioactive derivatives by modification of a SH group. (1997) (19)
Reaginic antibody formation in the mouse. IV. Adoptive anti-hapten IgE antibody response in irradiated recipients of hapten-primed cells and carrier-specific cells. (1974) (19)
Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. II. The 55-kDa glycosylation-inhibiting factor peptide is a derivative of TCR alpha-chain and a subunit of antigen-specific glycosylation-inhibiting factor. (1996) (19)
Ontogeny of IgE-bearing lymphocytes in the rat. (1978) (19)
Studies on the allergy-like food poisoning associated with putrefaction of marine products. I. Episodes of allergy-like food poisoning caused by samma sakuraboshi (dried seasoned saury) and other kinds of marine products. (1955) (19)
Biological Activities of Aggregated γ-Globulin VII. Minimum Size of Aggregated γ-Globulin or its Piece III Required for the Induction of Skin Reactivity and Complement Fixation (1965) (19)
Modulation of the biologic activities of IgE-binding factor. II. Physicochemical properties and cell sources of glycosylation-enhancing factor. (1983) (19)
Immunochemical properties of human gamma A isoagglutinin. II. The effect of reduction and alkylation. (1965) (18)
Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors. (1987) (18)
IgE formation in the rat following infection with Nippostrongylus brasiliensis. III. Soluble factor for the generation of IgE-bearing lymphocytes. (1977) (18)
Blocking of Prausnitz-Küstner sensitization with reagin by ‘A chain’ of human γ1A-globulin (1964) (18)
Physicochemical properties of human reaginic antibodies. 8. Effect of reduction and alkylation on gamma E antibodies. (1969) (18)
Chemistry and Biology of Immunoglobulin E (1973) (18)
High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells. (1997) (18)
Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR alpha-chain determinant. (1996) (17)
The Way We Walked with Immunology. (2018) (17)
BIOLOGIC ACTIVITIES OF AGGREGATED GAMMA-GLOBULIN. VI. AGGREGATED PRODUCTS OF RABBIT SERUM PROTEINS. (1963) (17)
A new concept of triggering mechanisms of IgE-mediated histamine release. (1978) (17)
A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks. (1989) (17)
Biological activities of aggregated gamma-globulin. V. Agglutination of erythrocytes and platelets. (1962) (16)
CHAPTER 5 – Role of IgE and IgG Antibodies in Reaginic Hypersensitivity in the Respiratory Tract* (1973) (16)
Biologic activity of soluble antigen-antibody complexes. IV. The inhibition of the skin reactivity of soluble complexes and the PCA reaction by heterologous complexes. (1959) (16)
Reaginic antibody formation in the mouse. X. Possible role of suppressor T cells in transient IgE antibody responses. (1978) (16)
Monoclonal antibody specific for T cell-derived human IgE binding factors. (1987) (15)
Stimulation of phospholipid methylation , Ca 2 + influx , and histamine release by bridging of IgE receptors on rat mast cells ( methyltransferase / anti-receptor antibodies / methyltransferase inhibitors ) (15)
Association of receptors for mouse IgE with the plasma membrane of rat mast cells. (1974) (15)
Association of I-J determinants with lipomodulin/macrocortin. (1986) (15)
Heterogeneity in antibodies specific for aggregated human gammaG-globulin. (1968) (15)
Treatment of ragweed hay fever with urea-denatured antigen E. (1980) (15)
Binding of rat IgE with the subcellular components of normal rat mast cells. (1976) (14)
Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation. (1988) (14)
Antigen-specific T cells that form IgE-potentiating factor, IgG-potentiating factor, and antigen-specific glycosylation-enhancing factor on antigenic stimulation. (1988) (14)
IgE-B cell-generating factor from lymph node cells of rats infected with Nippostrongylus brasiliensis. I. Source of IgE-B cell-generating factor. (1978) (14)
Studies on the allergy-like food poisoning associated with putrefaction of marine products. II. Separation of causative substance and some of its chemical characteristics. (1955) (14)
Modulation of the biologic activities of IgE binding factor. VI. The activation of phospholipase by glycosylation enhancing factor. (1984) (13)
T cell factors involved in the isotype-specific regulation of the IgE antibody response. (1987) (13)
Reaginic antibody formation in the mouse. V. Adoptive antihapten IgE antibody response of dinitrophenyl-keyhole limpet hemocyanin-primed spleen cells cultured with dinitrophenyl heterologous carrier conjugates. (1975) (13)
Target cells for an immunosuppressive cytokine, glycosylation-inhibiting factor. (1999) (13)
Immunoglobulin E. Current status and clinical laboratory applications. (1976) (13)
Pleiotropic Effect of Common Variants at ABO Glycosyltranferase Locus in 9q32 on Plasma Levels of Pancreatic Lipase and Angiotensin Converting Enzyme (2014) (13)
Antigenic Structure of γE-Gobulin and Reaginic Antibody (1967) (13)
Arthus type inflammation with rabbit gammam antibody. (1966) (13)
Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation. (1985) (13)
Immunoglobulin E. A new class of human immunoglobulin. (1968) (13)
T lymphocyte responses of murine lung: immunization with alloantigen induces accumulation of cytotoxic and other T lymphocytes in the lung. (1982) (13)
Fixation of C′ and C′la by Rabbit γG- and γM-Antibodies with Particulate and Soluble Antigens (1968) (12)
Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors. (1989) (12)
Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor. (1995) (12)
BIOLOGIC ACTIVITIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEXES. X. SKIN-REACTIVE PROPERTIES OF ALLERGEN-REAGIN COMPLEXES. (1965) (12)
Workshop on measurement of in vitro IgE synthesis and regulation of IgE synthesis. (1986) (12)
Relationship between T cell receptors and antigen-binding factors. II. Common antigenic determinants and epitope recognition shared by T cell receptors and antigen-binding factors. (1989) (12)
Effect of reduction and alkylation on allergen-combining properties of reaginic antibody. (1966) (11)
Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor alpha chain by suppressor T cells. (1996) (11)
Biochemical basis of antigen-specific suppressor T cell factors: controversies and possible answers. (2000) (11)
IgE-B cell generating factor from lymph node cells of rats infected with Nippostrongylus brasiliensis. III. Regulation of factor formation by anti-immunoglobulin. (1980) (11)
Detection of Five Components Having Antibody Activity in Rat Antisera.∗ † (1967) (10)
Development of Rat Mast Cells in Vitro (1976) (10)
Reaginic antibody formation in the mouse. IX. Enhancement of suppressor and helper cell activities of primed spleen cells. (1977) (10)
Evidence for antibody activity against the receptor for IgE in a rabbit antiserum prepared against IgE-receptor complexes. (1978) (10)
Characterization of the target cell receptor for IgE. V. Studies with an antiserum specific for the receptor. (1979) (10)
IgE-B cell-generating factor from lymph node cells of rats infected with Nippostrongylus brasiliensis. II. Effector mechanisms of IgE-B cell-generating factor. (1978) (10)
Demonstration of Fcgamma receptors on human basophil granulocytes. (1979) (10)
IgG diphtheria antitoxin responses from human tonsil lymphocytes induced by anti-gamma-chain antibodies. (1975) (10)
Molecular Bases of Passive Sensitization: I. Role of Disulfide Linkages in γ-Globulin Molecule (1961) (10)
Regulation of the IgE response. (1981) (10)
Comparison of reverse passive antiglobulin haemagglutination with double antibody radioimmunoassay for estimation of total human serum IgE. (1982) (10)
Studies on the allergy-like food poisoning associated with putrefaction of marine products. III. Physiological and pharmacological action of saurine, a vagusstimulant of unknown structure recently isolated by the authors, and its characteristics in developing allergy-like symptoms. (1955) (9)
BIOLOGIC ACTIVITY OF SOLUBLE ANTIGEN-ANTIBODY COMPLEXES. IX. SOLUBLE COMPLEXES OF RABBIT ANTIBODY WITH UNIVALENT AND DIVALENT HAPTENS. (1964) (9)
C′1 Fixation by Human Isoagglutinins: Fixation of C′1 by γG and γM but Not by γA Antibody (1966) (9)
The Identification and Significance of Gamma E (1969) (9)
Immunoglobulin E: Biosynthesis and Immunological Mechanisms of IgE-Mediated Hypersensitivity (1979) (9)
Reaginic antibodies. (1970) (9)
Transmission and regulation of triggering signals induced by bridging of IgE receptors on rat mast cells. (1981) (9)
T cell factors involved in the regulation of the IgE synthesis. (1987) (9)
Isotope-specific T cell factors for the IgE response. (1985) (9)
Histamine Release from Human Leukocytes by Anti-λE Antibodies (1969) (8)
IgE-binding factors. Selective regulation of the IgE response by T cell factors. (1985) (8)
MOLECULAR BASIS OF PASSIVE SENSITIZATION. II. THE ROLE OF FRAGMENT 3 OF GAMMA-GLOBULIN AND ITS DISULFIDE BONDS IN PASSIVE SENSITIZATION AND COMPLEMENT FIXATION. (1964) (8)
Studies on the Food Poisoning Associated with Putrefaction of Marine Products– I. Outbreaks of Allergy-like Food Poisoning Caused by “Samma Sakuraboshi” (Dried Seasoned Saury) and Canned Seasoned Mackerel (1955) (8)
Formation of IgE-binding factors by rat T lymphocytes. IV. Mechanisms for the formation of IgE-suppressive factors by antigen stimulation of BCG-primed spleen cells. (1982) (8)
Lymphocytes bearing receptors for IgE. III. Transition of Fc gamma R(+) cells to Fc epsilon R(4) cells by IgE. (1979) (8)
Effects of cyclophosphamide treatment and gamma irradiation of SJL mice on the IgE antibody response and the nature of IgE-binding factors. (1987) (8)
Biochemical characterization of murine glycosylation-inhibiting factor. (1991) (8)
Arthus Type Inflammation with Rabbit γM Antibody (1966) (8)
Degranulation of Human Basophil Leukocytes by Anti-γE Antibody (1971) (8)
Demonstration of human reagin in monkey tissues. V. In vitro passive sensitization of monkey ileum with absorbed globulin fractions from sera of patients sensitive to ragweed. (1968) (7)
Development of IgE-forming cells in vitro from rat mesenteric lymph node cells. (1978) (7)
Structure and biologic activity of immunoglobulin E. (1977) (7)
Half-life of guinea pig 1 globulin and 2 globulin antibodies. (1972) (7)
Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas. (1990) (7)
An antigenic determinant of human gamma-globulin susceptible to papain digestion. (1967) (7)
Augmentation of the antibody response by antigen-specific glycosylation-enhancing factor. (1987) (7)
Regulation of IgE biosynthesis. (1989) (7)
I‐J決定基とリポモジュリン/マクロコルチンとの関連性 (1986) (7)
Immunologic and clinical responses to ragweed extract and its allergoid (1975) (7)
Studies on the Food Poisining Associated with Putrefaction of Marine Products–m. Physiological and Pharmacological Properties of Newly Isolated Vagus-stimulant, Named “Saurine” (1955) (7)
Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor. (1993) (7)
IgE and IgG antibody responses during immunotherapy (1973) (6)
Is immunoglobulin E a “gatekeeper” for other antibodies? (1973) (6)
Formation of IgE-binding factors by lymphocytes of HIV-infected patients. (1989) (6)
Immunological events at the surface of basophil granulocytes and mast cells which induce degranulation. (1977) (6)
Studies on the Food Poisoning Associated with Putrefaction of Marine ProductsVi. Influence of Trimethylamine and Trimethylamine Oxide Added to Histamine or “Saurine” upon their Own Action in vivo (1956) (6)
Rabbit lymphocyte populations responding to haptenic and carrier determinants for DNA synthesis. (1975) (6)
IgE-class-specific immunosuppression in offspring by administration of anti-IgE to pregnant mice. (2019) (6)
Activation of Mast Cells for Mediator Release through IgE Receptors (Part 1 of 2) (1984) (6)
Regulatory effects of human IgE‐binding factors in the IgE synthesis by human and rat lymphocytes (1988) (6)
Distribution of γE-Forming Cells in Lymphoid Tissues of the Human and Monkey (1970) (6)
BIOLOGIC ACTIVITY OF SOLUBLE ANTIGEN-ANTIBODY COMPLEXES. VIII. COMPLEXES OF CHICKEN ANTIBODIES. (1963) (6)
Studies on the toxin-anaphylaxis and the rate of combination of diphtheria toxin and antitoxin in vitro. (1953) (5)
Binding of IgE molecules on human basophils (1973) (5)
Isotype Specific Regulation of IgE Antibody Response by IgE-Binding Factors (1983) (5)
BIOCHEMICAL BASIS OF THE ADJUVANT EFFECTS OF PERTUSSIS TOXIN FOR THE IgE RESPONSE1 (1985) (5)
Immunological Unresponsiveness to Specific Antigenic Determinants in Human γ G Globulin.∗ (1967) (5)
Pillars Article: Physicochemical Properties of Reaginic Antibody: V. Correlation of Reaginic Activity with γE-Globulin Antibody. J. Immunol. 1966. 97: 840-853. (2017) (5)
Participation of IL-4 in the formation of IgD-binding factors by antigen-primed mouse spleen cells. (1988) (5)
Presence of gammaE in nasal washings and sputum from asthmatic patients. (1970) (5)
Physiochemical properties of reaginic antibody. II. Characteristic properties of reaginic antibody different from human gamma-A-isohemagglutinin and gamma-D-globulin. (1966) (5)
Lymphocyte responses to ragweed antigens from different sources. (1979) (5)
Gamma Globulin and Molecular Mechanisms in Hypersensitivity Reactions (Part 2 of 2) (1963) (5)
On the nature of the presumed receptor for IgE on mast cells. V. Enhanced binding of 125I-labeled IgE to cell-free particulate fractions in the presence of protease inhibitors. (1973) (5)
Modulation of the biologic activities of IgE-binding factors. VII. Biochemical mechanisms by which glycosylation-enhancing factor activates phospholipase in lymphocytes. (1985) (4)
Association of IgE with reaginic activity in sera from grass pollen- and horse dander-sensitive individuals. (1970) (4)
In vitro modulation of antigen-primed T cells by a glycosylation-inhibiting factor that regulates the formation of antigen-specific suppressive factors. (1987) (4)
Clinical Correlates of Serum IgE in Asthmatic Children (1970) (4)
Biologic Activities of Aggregated γ-Globulin (1962) (4)
Dean's lecture. Immunoglobulin E and reaginic hypersensitivity. (1974) (4)
Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient. (1992) (4)
Enhancement of antibody responses by IgD-binding factors induced by anti-IgD treatment of spleen cells. (1988) (4)
Reaginic Antibody Formation in the Mouse (1972) (4)
Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2. (1994) (4)
INTERNATIONAL CONGRESS SERIES, NO. 323: proceedings of the VIIIth congress of the international association of allergology, Tokyo, October 14-20, 1973 (1974) (4)
Specific IgE antibody measurements in the diagnosis of ragweed hay fever (1973) (4)
Possible approaches to turn off the IgE response. (1982) (4)
Studies on the Toxin-anaphylaxis (1952) (3)
Ontogeny and development of IgE-bearing B lymphocytes. (1979) (3)
Studies on immunoglobulin E: the impact of a sojourn with Professor Dan H. Campbell at Cal-Tech. (1975) (3)
Complement-Fixing Activity of Rabbit Antibody Reconstructed from Half Molecules.∗ (1965) (3)
A method to generate antigen-specific suppressor T cells in vitro from peripheral blood T cells of honey bee venom-sensitive, allergic patients. (1990) (3)
Studies on the Food Poisoning Associated with Putrefaction of Marine Products–IV -Epidemiology and the Causative Agents of the Outbreaks of Allergy-like Food Poisoning Caused by Cooked Frigate mackerel Meat at Kawasaki and by “Samma Sakuraboshi “at Hamamatsu (1955) (3)
Effect of phospholipase A2 inhibitors on mouse T lymphocytes. II. Phospholipase A2 inhibitors induce T cell hybridomas and a T cell clone for the formation of glycosylation-inhibiting factor. (1990) (3)
Physicochemical properties of reaginic antibody. 3. Further studies on the reaginic antibody in gamma-A-globulin preparations. (1966) (3)
MOLECULAR BASES FOR BIOLOGIC ACTIVITIES OF ANTIGEN—ANTIBODY COMPLEXES AND AGGREGATED γ-GLOBULIN* (1968) (3)
A Comparative Antigenic Study of λE-Globulin and Myeloma-IgND (1969) (3)
Induction and Suppression of IgE Antibody Response (1976) (3)
Controversial issues and possible answers on the antigen-specific regulation of the IgE antibody response. (1996) (3)
QUANTITATIVE STUDIES ON ANAPHYLAXIS IN VITRO (1956) (3)
Biological activity of soluble antigen-antibody complexes. VI. Complexes in excess antibody. (1961) (3)
Studies on the mechanism of antitoxic immunity (1953) (3)
BIOLOGICAL ACTIVITIES OF AGGREGATED GAMMA-GLOBULIN. VII. MINIMUM SIZE OF AGGREGATED GAMMA-GLOBULIN OR ITS PIECE 3 REQUIRED FOR THE INDUCTION OF SKIN REACTIVITY AND COMPLEMENT FIXATION. (1965) (3)
Biochemical identification of glycosylation inhibiting factor. (1990) (3)
Skin reactions to anti-gammaE antibody in atopic, nonatopic, and immunologically deficiency children and adults. (1969) (3)
Requirement of certain epitope specificities of glycosylation inhibiting factor for the suppression of in vivo IgE and IgG antibody responses. (1992) (3)
DIRECT DEMONSTRATION OF REAGIN ACTIVITY IN PURIFIED GAMMA 1A GLOBULIN. (1964) (3)
BLOCKING OF PRAUSNITZ-KUESTNER SENSITIZATION WITH REAGIN BY NORMAL HUMAN BETA-2A GLOBULIN. (1963) (3)
Biology of Immunoglobulin E (Part 2 of 2) (1975) (2)
Symptoms and IgE antibody levels in children with hay fever (1973) (2)
Molecular Basis of Passive Sensitization (1964) (2)
Studies on the relationship between toxin anaphylaxis and antitoxic immunity. III. Significance of allergic reaction on the neutralization of toxin injected intracutaneously. (1957) (2)
Effect of phospholipase A2 inhibitors on mouse T lymphocytes. I. Phospholipase A2 inhibitors exert similar immunological activities as glycosylation inhibiting factor. (1989) (2)
Mechanisms of reaginic hypersensitivity and immunotherapy (1978) (2)
Quantitative studies on anaphylaxis in vitro. I. Proportion of antigen concentration to tissue antibody concentration in toxin-anaphylaxis of diphtheria. (1956) (2)
BLOCKING OF PRAUSNITZ-KUESTNER SENSITIZATION WITH REAGIN BY 'A CHAIN' OF HUMAN GAMMA1A-GLOBULIN. (1964) (2)
Biological properties of a recombinant human immunoglobulin (1999) (2)
Lymphocytes Bearing Receptors for IgE (1979) (2)
Quantitative studies on anaphylaxis in vitro. II. Studies on the species difference of diphtheria antitoxin in sensitizing activity. (1957) (2)
Comparative studies on serological tests for syphilis. (1954) (2)
Studies on the relationship between toxin-anaphylaxis and antitoxic immunity. I. Quantitative studies on the toxin-anaphylaxis in vitro. (1954) (2)
An Outbreak of Allergy-like Food Poisoning Caused by “Sashimi” (Sliced Raw Fish Flesh) and the Isolation of Responsible Bacterium, Proteus morganii (1956) (2)
Antigenic Determinants Specific for Aggregated γG-Globulins (1968) (2)
Studies on the allergy-like food poisoning associated with putrefaction of marine products. IV. Effect of trimethylamine and trimethylamine oxide added to histamine or saurine upon their own physiological action. (1955) (2)
182 Biochemical analysis of early membrane events induced by bridging of IgE receptors on human mast cells (1983) (2)
Studies on the Food Poisoning Associated with Putrefaction of Marine Products–V. Influence of Trimethylamine and Trimethylamine Oxide Added to Histamine or “Saurine “upon Their Own Action Tested on the Contractility of Intestine and Uterus of Guinea Pigs (1956) (2)
Regulation of immunoglobin E biosynthesis. (1989) (2)
Serologic, biologic and western blot analysis of human IgE-binding factor derived from a T cell hybridoma maintained in protein-free medium. (1992) (1)
Studies on the Toxinanaphylaxis (1952) (1)
83. Histamine release from rat mast cells by antibodies against IgE-receptors (1978) (1)
Regulation of anti-ovalbumin (oa) ige and igg antibody responses in the mouse by administration of urea-denatured oa. Abstr. (1975) (1)
Lipids and the Receptor Mediated Release of Histamine (1982) (1)
Induction of passive cutaneous anaphylaxis in monkeys by human gamma-E antibody. (1967) (1)
Immunochemical Properties of Human γA Isoagglutinin (1965) (1)
Immunogenic Properties of Modified Antigen E (1974) (1)
T Cell Factors Involved in the Regulation of the IgE Antibody Response (1986) (1)
IL-4-producing murine T helper cell line provides help for in vitro production of IgE. (1991) (1)
Gamma Globulin and Molecular Mechanisms in Hypersensitivity Reactions (Part 1 of 2) (1963) (1)
Physicochemical and Antigenic Studies on Human γE in Respiratory Fluid (1970) (1)
Studies on the relationship between toxin anaphylaxis and anatitoxic immunity. II. Significance of the relation between the tissue antitoxin and circulating antitoxin on the toxin anaphylaxis and antitoxic immunity. (1955) (1)
Lymphocytes bearing Fc receptors for IgE. II. Induction of Fcepsilon-receptor bearing rat lymphocytes by IgE. (1979) (1)
Cellular mechanisms of IgE antibody response. (1975) (1)
The origin and nature of antigen-binding factors having affinity for nominal antigens (1990) (1)
Membrane components of rat mast cells containing IgE receptor (1975) (1)
Quantitative studies on anaphylaxis in vitro. III. Comparison between Schultz-Dale's reaction and serological reactions in vitro. (1957) (1)
Possible role of FcR+ T cells in the regulation of the IgE response (1985) (1)
Cloning of an IgE Immunoregulatory Factor by Expression in Mammalian Cells (1985) (1)
Studies on the mechanism of the flocculation (1953) (1)
[(IgE) immunoglobulins in acute protein-calorie malnutrition]. (1971) (1)
Solubilization and initial biochemical characterization of an IgE-destroying enzyme on rat peritoneal mast cells. (1982) (1)
Biologic Activity of Soluble Antigen-Antibody Complexes (1959) (1)
Selective differentiation andproliferation ofhematopoietic cells induced byrecombinant humaninterleukins (1988) (1)
Construction of Human Suppressor T Cell Hybridomas That Produce Glycosylation Inhibiting Factors from Peripheral Blood Mononuclear Cells of Bee Venom Sensitive Patients (1991) (0)
Heterogeneity in Antibodies Specific for Aggregated Human γG-Globulin (1968) (0)
Biochemical identification of glycosylation inhibiting factor (phospholipase inhibitory protein/lipocortin/suppressor T-cell factor) (2016) (0)
Kimishige Ishizaka. Tokyo, Japan. (2014) (0)
T H E BIOLOGICAL ACTIVITY OF SOLUBLE ANTIGEN-ANTIBODY COMPLEXES II. PHYSICAL PROPERTIES OF SOLUBLE COMPLEXES HAVING SKIN-IRRITATING ACTMT¥* (2003) (0)
Pillars Article: Physico-Chemical Properties of Human Reaginic Antibody: IV. Presence of a Unique Immunoglobulin as a Carrier of Reaginic Activity. J. Immunol. 1966. 97: 75-85. (2017) (0)
Allergology: proceedings of the VIIIth congress of the international association of allergology, Tokyo, October 14-20, 1973 (1974) (0)
A process for the production of recombinant, biologically active polypeptide (1994) (0)
Anti-hapten reaginic antibody formation in the mouse. Abstr. (1973) (0)
Development ofhumanmastcells fromumbilical cordbloodcells byrecombinant humanandmurinec-kit ligand (1993) (0)
Formation of IgE-specific suppressive factor and antigen-specific glycosylation inhibiting factor by an antigen-specific T cell clone and hybridomas (1985) (0)
Mechanisms of Passive Sensitization (1970) (0)
Contents, Vol. 66, Supplement 1, 1981 (1981) (0)
Characteristics of carrier-specific regulatory T cells. (1989) (0)
Symposium on allergy (1961) (0)
[Immune tolerance, anergy, suppressor T cells]. (1994) (0)
Regulation of IgE response by IgE binding factors. (1981) (0)
Acquired Immunodeficiency Syndrome Progress in Allergy (2015) (0)
Activation of Mast Cells for Mediator Release through IgE Receptors (Part 2 of 2) (1984) (0)
Switching of biologic activities and carbohydrate moieties of human IgE-binding factors from T cell hybridomas (1985) (0)
Role of Glycosylation Inhibiting Factor (GIF), a Phospholipase Inhibitory Protein, in the Generation of Antigen-Specific Suppressor T Cells (1987) (0)
Suppression of delayed type hypersensitivity and mixed lymphocyte response (MLR) to allogenic cells by cell transfusion and corticosteroid treatment (1985) (0)
In vivo immunosuppression by derivatives of recombinant glycosylation inhibiting factor (1996) (0)
3 What is the cell-derived,antigen-specific immuno-regulatory molecules? (1994) (0)
Mast Cell Activation and Mediator Release Progress in Allergy (2015) (0)
Cellular mechanisms for the formation of a soluble form derivative of TCRa chain by suppressor t cells (1996) (0)
Biologic Activity of Aggregated γ-Globulin (1960) (0)
Association of the (1995) (0)
Nomenclature of the Fc receptors (1998) (0)
Biochemical mechanism of histamine release from rat mast cells and basophilic leukemia cells (1982) (0)
25 – IgE-Mediated Responses in the Mucosal Immune System (1994) (0)
Formation ofIgE-binding factors byTcells ofpatients infected withhumanimmunodeficiency virus type1 (1988) (0)
Membrane Activation in Immunologically Relevant Cells Progress in Allergy Activation in Immunologically Relevant (2015) (0)
Regulation of the IgE antibody response. (1989) (0)
Physicochemical Properties of Human Reaginic Antibodies (1969) (0)
Possible role of IgD-binding factors in immune response. (1990) (0)
An Outbreak of Allergy-like Food Poisoning Caused by "Sashimi" of Parathunnus mebachi and the Isolation of Causative Bacteria (2007) (0)
IgE synthesis in the rat rollowing infection with Nippostrongylus brasiliensis (1976) (0)
Immunoglobulin E: a new class of human immunoglobulin. (1968) (0)
In Honour of Paul Kallós (1987) (0)
Contents, Vol. 82, 1987 (1987) (0)
Structural analysis of glycosylation inhibiting factor (1996) (0)
Possible Approaches to Controlling the IgE Antibody Response (1991) (0)
Reversed Type Allergic Skin Reactions by Anti-γE-Globulin Antibodies in Humans and Monkeys (1968) (0)
Suppression if ige and igg antibody responses by specific suppressor t cells. Abstr. (1976) (0)
Ige Binding Factor(S) in Atopic Eczema (1983) (0)
Development of Mast Cells in Vitro (1977) (0)
[Unknown episodes on IgE]. (1997) (0)
Complement-Fixing Activity of Antibodies Associated with Different Classes of Immunoglobulins (1969) (0)
Stimulation ofphospholipid methylation, Ca2+influx, andhistamine release bybridging ofIgEreceptors onratmastcells (1980) (0)
Regulatory role of t cells in the development of b memory cells for ige and igg classes. Abstr. (1978) (0)
Administration of anti‐IgE to pregnant mice caused IgE‐class‐specific immunosuppression in offspring: 904 (2019) (0)
Fcepsilon receptor bearing lymphocytes in the mouse. Abstr. (1981) (0)
Mutants FactorRecombinant Glycosylation-Inhibiting Immunosuppressive Activities of Kimishige (1998) (0)
Conversion of inactive glycosylation inhibiting factor (GIF) peptide to bioactive derivatives by modification of its sulfhydryl group (S) (1996) (0)
Facteurs d'inhibition de la glycosylation (1988) (0)
3.異種免疫グロブリンに属する抗体による補体結合性の差異(日米補体セミナー記録) (1970) (0)
PHARMACOLOGICAL MODULATIONS OF IgE-BINDING FACTOR (1983) (0)
Regulation of Antibody Response in Vitro (1971) (0)
Presence of radio-resistant antigen-primed b cells involved in persistent antibody formation. Abstr. (1979) (0)
Biochemical mechanisms for modulation of IgE-binding factors by glycosylation-enhancing factor (1984) (0)
Molecular Bases of Passive Sensitization (1961) (0)
IgE SYNTHESIS AND ITS REGULATION (1990) (0)
Presence of the 55 kDa glycosylation inhibiting factor in human serum. (2000) (0)
Immunogenic properties of modified antigen e part 2 ability of urea denatured antigen and alpha poly peptide chain to prime thymus derived cells specific for antigen e (1975) (0)
Structure and functions of low affinity Fc receptors. (1989) (0)
Contents, Vol. 95, 1991 (1991) (0)
Biology of Immunoglobulin E (Part 1 of 2) (1975) (0)
PRESENCE OF REAGIN AND GAMMA-GLOBULIN IN SALIVA. (1964) (0)
Five great allergists (2006) (0)

This paper list is powered by the following services:

Other Resources About Kimishige Ishizaka

en.wikipedia.org

What Schools Are Affiliated With Kimishige Ishizaka?

Kimishige Ishizaka is affiliated with the following schools:

Image Attributions

Image Source for Kimishige Ishizaka